Nisa Investment Advisors’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81K Hold
1,026
﹤0.01% 2766
2026
Q1
$1.95K Hold
1,026
﹤0.01% 2618
2025
Q4
$1.63K Hold
1,026
﹤0.01% 2638
2025
Q3
$2.39K Hold
1,026
﹤0.01% 2584
2025
Q2
$1.29K Sell
1,026
-1,398
-58% -$1.38K ﹤0.01% 2692
2025
Q1
$2.21K Sell
2,424
-7,483
-76% -$9.73K ﹤0.01% 2446
2024
Q4
$15.8K Buy
9,907
+576
+6% +$1.16K ﹤0.01% 2014
2024
Q3
$18.3K Buy
9,331
+4,033
+76% +$8.26K ﹤0.01% 1936
2024
Q2
$8.69K Buy
5,298
+4,223
+393% +$13.5K ﹤0.01% 2188
2024
Q1
$5.53K Buy
1,075
+15
+1% +$92 ﹤0.01% 2109
2023
Q4
$6.07K Hold
1,060
﹤0.01% 2107
2023
Q3
$5.07K Hold
1,060
﹤0.01% 2280
2023
Q2
$4.5K Buy
1,060
+30
+3% +$135 ﹤0.01% 2331
2023
Q1
$5K Buy
1,030
+30
+3% +$187 ﹤0.01% 2240
2022
Q4
$6K Sell
1,000
-56
-5% -$498 ﹤0.01% 2275
2022
Q3
$10K Sell
1,056
-724
-41% -$6.75K ﹤0.01% 2182
2022
Q2
$10K Buy
+1,780
New +$13.6K ﹤0.01% 2183

Other funds holding CRBU

Nisa Investment Advisors's CRBU Position: Q2 2026 in Review

Nisa Investment Advisors held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 1,026 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2766.

Nisa Investment Advisors first reported a position in CRBU in Q2 2022 and has held it in 17 quarters since. The position peaked at $18.3K in Q3 2024. 51 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Nisa Investment Advisors held 1,026 shares of Caribou Biosciences worth $1.81K as of Q2 2026.
  • Nisa Investment Advisors left its Caribou Biosciences share count unchanged in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2766 holding.
  • Nisa Investment Advisors first reported a position in Caribou Biosciences in Q2 2022 and has held it in 17 quarters since.
  • Nisa Investment Advisors's Caribou Biosciences position peaked at $18.3K in Q3 2024.
  • 51 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.